04:13 PM EDT, 07/15/2025 (MT Newswires) -- Jeffrey Bluestone, Director, on July 14, 2025, sold 5,000 shares in Gilead Sciences ( GILD ) for $548,700. Following the Form 4 filing with the SEC, Bluestone has control over a total of 8,920 common shares of the company, with 8,920 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/882095/000112760225019182/xslF345X05/form4.xml